 | • レポートコード：GIR201100512 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、アルファシヌクレインの世界市場を調査対象にし、アルファシヌクレインの市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（AV-1950R、AV-1947D、BAN-0805、BIIB-054、DPC-003、その他）、用途別分析（多系統萎縮症、神経変性疾患、レビー小体型認知症、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：AC Immune SA、ICB International Inc、Biogen Inc、AFFiRiS AG、H. Lundbeck A/S、BioArctic AB、Neuropore Therapies Inc、Genmab A/S、Evotec AG、MedImmune LLC、nLife Therapeutics SL、reMYND NV、Prothena Corp Plc、QR Pharma Inc ・メーカー別販売量、売上、市場シェア ・アルファシヌクレインの地域別市場分析 ・アルファシヌクレインの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・アルファシヌクレインのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・アルファシヌクレインのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・アルファシヌクレインの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・アルファシヌクレインの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・アルファシヌクレインの種類別市場規模2015-2020：AV-1950R、AV-1947D、BAN-0805、BIIB-054、DPC-003、その他 ・アルファシヌクレインの用途別市場規模2015-2020：多系統萎縮症、神経変性疾患、レビー小体型認知症、その他 ・アルファシヌクレインの世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Alpha Synuclein market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Alpha Synuclein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Alpha Synuclein market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Alpha Synuclein market has been segmented into
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
By Application, Alpha Synuclein has been segmented into:
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Alpha Synuclein market presented in the report. This section sheds light on the sales growth of different regional and country-level Alpha Synuclein markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Alpha Synuclein market.
The report offers in-depth assessment of the growth and other aspects of the Alpha Synuclein market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Alpha Synuclein Market Share Analysis
Alpha Synuclein competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Alpha Synuclein sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Alpha Synuclein sales, revenue and market share for each player covered in this report.
The major players covered in Alpha Synuclein are:
AC Immune SA
ICB International Inc
Biogen Inc
AFFiRiS AG
H. Lundbeck A/S
BioArctic AB
Neuropore Therapies Inc
Genmab A/S
Evotec AG
MedImmune LLC
nLife Therapeutics SL
reMYND NV
Prothena Corp Plc
QR Pharma Inc
Among other players domestic and global, Alpha Synuclein market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Alpha Synuclein product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Alpha Synuclein, with price, sales, revenue and global market share of Alpha Synuclein in 2018 and 2019.
Chapter 3, the Alpha Synuclein competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Alpha Synuclein breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Alpha Synuclein market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Alpha Synuclein sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Alpha Synuclein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Alpha Synuclein Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 AV-1950R
1.2.3 AV-1947D
1.2.4 BAN-0805
1.2.5 BIIB-054
1.2.6 DPC-003
1.2.7 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Alpha Synuclein Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Multiple System Atrophy
1.3.3 Neurodegenerateive Disease
1.3.4 Lewy Body Dementia
1.3.5 Others
1.4 Overview of Global Alpha Synuclein Market
1.4.1 Global Alpha Synuclein Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AC Immune SA
2.1.1 AC Immune SA Details
2.1.2 AC Immune SA Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AC Immune SA SWOT Analysis
2.1.4 AC Immune SA Product and Services
2.1.5 AC Immune SA Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ICB International Inc
2.2.1 ICB International Inc Details
2.2.2 ICB International Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ICB International Inc SWOT Analysis
2.2.4 ICB International Inc Product and Services
2.2.5 ICB International Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biogen Inc
2.3.1 Biogen Inc Details
2.3.2 Biogen Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Biogen Inc SWOT Analysis
2.3.4 Biogen Inc Product and Services
2.3.5 Biogen Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 AFFiRiS AG
2.4.1 AFFiRiS AG Details
2.4.2 AFFiRiS AG Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AFFiRiS AG SWOT Analysis
2.4.4 AFFiRiS AG Product and Services
2.4.5 AFFiRiS AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 H. Lundbeck A/S
2.5.1 H. Lundbeck A/S Details
2.5.2 H. Lundbeck A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 H. Lundbeck A/S SWOT Analysis
2.5.4 H. Lundbeck A/S Product and Services
2.5.5 H. Lundbeck A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioArctic AB
2.6.1 BioArctic AB Details
2.6.2 BioArctic AB Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioArctic AB SWOT Analysis
2.6.4 BioArctic AB Product and Services
2.6.5 BioArctic AB Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Neuropore Therapies Inc
2.7.1 Neuropore Therapies Inc Details
2.7.2 Neuropore Therapies Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Neuropore Therapies Inc SWOT Analysis
2.7.4 Neuropore Therapies Inc Product and Services
2.7.5 Neuropore Therapies Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genmab A/S
2.8.1 Genmab A/S Details
2.8.2 Genmab A/S Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genmab A/S SWOT Analysis
2.8.4 Genmab A/S Product and Services
2.8.5 Genmab A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Evotec AG
2.9.1 Evotec AG Details
2.9.2 Evotec AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Evotec AG SWOT Analysis
2.9.4 Evotec AG Product and Services
2.9.5 Evotec AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 MedImmune LLC
2.10.1 MedImmune LLC Details
2.10.2 MedImmune LLC Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MedImmune LLC SWOT Analysis
2.10.4 MedImmune LLC Product and Services
2.10.5 MedImmune LLC Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 nLife Therapeutics SL
2.11.1 nLife Therapeutics SL Details
2.11.2 nLife Therapeutics SL Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 nLife Therapeutics SL SWOT Analysis
2.11.4 nLife Therapeutics SL Product and Services
2.11.5 nLife Therapeutics SL Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 reMYND NV
2.12.1 reMYND NV Details
2.12.2 reMYND NV Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 reMYND NV SWOT Analysis
2.12.4 reMYND NV Product and Services
2.12.5 reMYND NV Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Prothena Corp Plc
2.13.1 Prothena Corp Plc Details
2.13.2 Prothena Corp Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Prothena Corp Plc SWOT Analysis
2.13.4 Prothena Corp Plc Product and Services
2.13.5 Prothena Corp Plc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 QR Pharma Inc
2.14.1 QR Pharma Inc Details
2.14.2 QR Pharma Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 QR Pharma Inc SWOT Analysis
2.14.4 QR Pharma Inc Product and Services
2.14.5 QR Pharma Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Alpha Synuclein Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Alpha Synuclein Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Alpha Synuclein Manufacturer Market Share in 2019
3.3.2 Top 6 Alpha Synuclein Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Alpha Synuclein Sales, Revenue and Market Share by Regions
4.1.1 Global Alpha Synuclein Sales and Market Share by Regions (2015-2020)
4.1.2 Global Alpha Synuclein Revenue and Market Share by Regions (2015-2020)
4.2 North America Alpha Synuclein Sales and Growth Rate (2015-2020)
4.3 Europe Alpha Synuclein Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Alpha Synuclein Sales and Growth Rate (2015-2020)
4.5 South America Alpha Synuclein Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Alpha Synuclein Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Alpha Synuclein Sales, Revenue and Market Share by Country
5.1.1 North America Alpha Synuclein Sales and Market Share by Country (2015-2020)
5.1.2 North America Alpha Synuclein Revenue and Market Share by Country (2015-2020)
5.2 United States Alpha Synuclein Sales and Growth Rate (2015-2020)
5.3 Canada Alpha Synuclein Sales and Growth Rate (2015-2020)
5.4 Mexico Alpha Synuclein Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Alpha Synuclein Sales, Revenue and Market Share by Country
6.1.1 Europe Alpha Synuclein Sales and Market Share by Country (2015-2020)
6.1.2 Europe Alpha Synuclein Revenue and Market Share by Country (2015-2020)
6.2 Germany Alpha Synuclein Sales and Growth Rate (2015-2020)
6.3 UK Alpha Synuclein Sales and Growth Rate (2015-2020)
6.4 France Alpha Synuclein Sales and Growth Rate (2015-2020)
6.5 Russia Alpha Synuclein Sales and Growth Rate (2015-2020)
6.6 Italy Alpha Synuclein Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Alpha Synuclein Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Alpha Synuclein Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Alpha Synuclein Revenue and Market Share by Regions (2015-2020)
7.2 China Alpha Synuclein Sales and Growth Rate (2015-2020)
7.3 Japan Alpha Synuclein Sales and Growth Rate (2015-2020)
7.4 Korea Alpha Synuclein Sales and Growth Rate (2015-2020)
7.5 India Alpha Synuclein Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Alpha Synuclein Sales and Growth Rate (2015-2020)
7.7 Australia Alpha Synuclein Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Alpha Synuclein Sales, Revenue and Market Share by Country
8.1.1 South America Alpha Synuclein Sales and Market Share by Country (2015-2020)
8.1.2 South America Alpha Synuclein Revenue and Market Share by Country (2015-2020)
8.2 Brazil Alpha Synuclein Sales and Growth Rate (2015-2020)
8.3 Argentina Alpha Synuclein Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Alpha Synuclein Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Alpha Synuclein Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Alpha Synuclein Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Alpha Synuclein Sales and Growth Rate (2015-2020)
9.3 Turkey Alpha Synuclein Sales and Growth Rate (2015-2020)
9.4 Egypt Alpha Synuclein Sales and Growth Rate (2015-2020)
9.5 South Africa Alpha Synuclein Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Alpha Synuclein Sales and Market Share by Type (2015-2020)
10.2 Global Alpha Synuclein Revenue and Market Share by Type (2015-2020)
10.3 Global Alpha Synuclein Price by Type (2015-2020)
11 Global Alpha Synuclein Market Segment by Application
11.1 Global Alpha Synuclein Sales Market Share by Application (2015-2020)
11.2 Global Alpha Synuclein Revenue Market Share by Application (2015-2020)
11.3 Global Alpha Synuclein Price by Application (2015-2020)
12 Market Forecast
12.1 Global Alpha Synuclein Sales, Revenue and Growth Rate (2021-2025)
12.2 Alpha Synuclein Market Forecast by Regions (2021-2025)
12.2.1 North America Alpha Synuclein Market Forecast (2021-2025)
12.2.2 Europe Alpha Synuclein Market Forecast (2021-2025)
12.2.3 Asia-Pacific Alpha Synuclein Market Forecast (2021-2025)
12.2.4 South America Alpha Synuclein Market Forecast (2021-2025)
12.2.5 Middle East & Africa Alpha Synuclein Market Forecast (2021-2025)
12.3 Alpha Synuclein Market Forecast by Type (2021-2025)
12.3.1 Global Alpha Synuclein Sales Forecast by Type (2021-2025)
12.3.2 Global Alpha Synuclein Market Share Forecast by Type (2021-2025)
12.4 Alpha Synuclein Market Forecast by Application (2021-2025)
12.4.1 Global Alpha Synuclein Sales Forecast by Application (2021-2025)
12.4.2 Global Alpha Synuclein Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Alpha Synuclein Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Alpha Synuclein by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Alpha Synuclein Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. AC Immune SA Basic Information, Manufacturing Base and Competitors
Table 8. AC Immune SA Alpha Synuclein Major Business
Table 9. AC Immune SA Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 10. AC Immune SA SWOT Analysis
Table 11. AC Immune SA Alpha Synuclein Product and Services
Table 12. AC Immune SA Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ICB International Inc Basic Information, Manufacturing Base and Competitors
Table 14. ICB International Inc Alpha Synuclein Major Business
Table 15. ICB International Inc Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 16. ICB International Inc SWOT Analysis
Table 17. ICB International Inc Alpha Synuclein Product and Services
Table 18. ICB International Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Biogen Inc Basic Information, Manufacturing Base and Competitors
Table 20. Biogen Inc Alpha Synuclein Major Business
Table 21. Biogen Inc Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 22. Biogen Inc SWOT Analysis
Table 23. Biogen Inc Alpha Synuclein Product and Services
Table 24. Biogen Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. AFFiRiS AG Basic Information, Manufacturing Base and Competitors
Table 26. AFFiRiS AG Alpha Synuclein Major Business
Table 27. AFFiRiS AG Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 28. AFFiRiS AG SWOT Analysis
Table 29. AFFiRiS AG Alpha Synuclein Product and Services
Table 30. AFFiRiS AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. H. Lundbeck A/S Basic Information, Manufacturing Base and Competitors
Table 32. H. Lundbeck A/S Alpha Synuclein Major Business
Table 33. H. Lundbeck A/S Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 34. H. Lundbeck A/S SWOT Analysis
Table 35. H. Lundbeck A/S Alpha Synuclein Product and Services
Table 36. H. Lundbeck A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. BioArctic AB Basic Information, Manufacturing Base and Competitors
Table 38. BioArctic AB Alpha Synuclein Major Business
Table 39. BioArctic AB Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 40. BioArctic AB SWOT Analysis
Table 41. BioArctic AB Alpha Synuclein Product and Services
Table 42. BioArctic AB Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Neuropore Therapies Inc Basic Information, Manufacturing Base and Competitors
Table 44. Neuropore Therapies Inc Alpha Synuclein Major Business
Table 45. Neuropore Therapies Inc Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 46. Neuropore Therapies Inc SWOT Analysis
Table 47. Neuropore Therapies Inc Alpha Synuclein Product and Services
Table 48. Neuropore Therapies Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genmab A/S Basic Information, Manufacturing Base and Competitors
Table 50. Genmab A/S Alpha Synuclein Major Business
Table 51. Genmab A/S Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 52. Genmab A/S SWOT Analysis
Table 53. Genmab A/S Alpha Synuclein Product and Services
Table 54. Genmab A/S Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Evotec AG Basic Information, Manufacturing Base and Competitors
Table 56. Evotec AG Alpha Synuclein Major Business
Table 57. Evotec AG Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 58. Evotec AG SWOT Analysis
Table 59. Evotec AG Alpha Synuclein Product and Services
Table 60. Evotec AG Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 62. MedImmune LLC Alpha Synuclein Major Business
Table 63. MedImmune LLC Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 64. MedImmune LLC SWOT Analysis
Table 65. MedImmune LLC Alpha Synuclein Product and Services
Table 66. MedImmune LLC Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. nLife Therapeutics SL Basic Information, Manufacturing Base and Competitors
Table 68. nLife Therapeutics SL Alpha Synuclein Major Business
Table 69. nLife Therapeutics SL Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 70. nLife Therapeutics SL SWOT Analysis
Table 71. nLife Therapeutics SL Alpha Synuclein Product and Services
Table 72. nLife Therapeutics SL Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. reMYND NV Basic Information, Manufacturing Base and Competitors
Table 74. reMYND NV Alpha Synuclein Major Business
Table 75. reMYND NV Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 76. reMYND NV SWOT Analysis
Table 77. reMYND NV Alpha Synuclein Product and Services
Table 78. reMYND NV Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Prothena Corp Plc Basic Information, Manufacturing Base and Competitors
Table 80. Prothena Corp Plc Alpha Synuclein Major Business
Table 81. Prothena Corp Plc Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 82. Prothena Corp Plc SWOT Analysis
Table 83. Prothena Corp Plc Alpha Synuclein Product and Services
Table 84. Prothena Corp Plc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. QR Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 86. QR Pharma Inc Alpha Synuclein Major Business
Table 87. QR Pharma Inc Alpha Synuclein Total Revenue (USD Million) (2018-2019)
Table 88. QR Pharma Inc SWOT Analysis
Table 89. QR Pharma Inc Alpha Synuclein Product and Services
Table 90. QR Pharma Inc Alpha Synuclein Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. Global Alpha Synuclein Sales by Manufacturer (2018-2019) (K Pcs)
Table 92. Global Alpha Synuclein Revenue by Manufacturer (2018-2019) (USD Million)
Table 93. Global Alpha Synuclein Sales by Regions (2015-2020) (K Pcs)
Table 94. Global Alpha Synuclein Sales Market Share by Regions (2015-2020)
Table 95. Global Alpha Synuclein Revenue by Regions (2015-2020) (USD Million)
Table 96. North America Alpha Synuclein Sales by Countries (2015-2020) (K Pcs)
Table 97. North America Alpha Synuclein Sales Market Share by Countries (2015-2020)
Table 98. North America Alpha Synuclein Revenue by Countries (2015-2020) (USD Million)
Table 99. North America Alpha Synuclein Revenue Market Share by Countries (2015-2020)
Table 100. Europe Alpha Synuclein Sales by Countries (2015-2020) (K Pcs)
Table 101. Europe Alpha Synuclein Sales Market Share by Countries (2015-2020)
Table 102. Europe Alpha Synuclein Revenue by Countries (2015-2020) (USD Million)
Table 103. Asia-Pacific Alpha Synuclein Sales by Regions (2015-2020) (K Pcs)
Table 104. Asia-Pacific Alpha Synuclein Sales Market Share by Regions (2015-2020)
Table 105. Asia-Pacific Alpha Synuclein Revenue by Regions (2015-2020) (USD Million)
Table 106. South America Alpha Synuclein Sales by Countries (2015-2020) (K Pcs)
Table 107. South America Alpha Synuclein Sales Market Share by Countries (2015-2020)
Table 108. South America Alpha Synuclein Revenue by Countries (2015-2020) (USD Million)
Table 109. South America Alpha Synuclein Revenue Market Share by Countries (2015-2020)
Table 110. Middle East & Africa Alpha Synuclein Sales by Countries (2015-2020) (K Pcs)
Table 111. Middle East & Africa Alpha Synuclein Sales Market Share by Countries (2015-2020)
Table 112. Middle East & Africa Alpha Synuclein Revenue by Countries (2015-2020) (USD Million)
Table 113. Middle East & Africa Alpha Synuclein Revenue Market Share by Countries (2015-2020)
Table 114. Global Alpha Synuclein Sales by Type (2015-2020) (K Pcs)
Table 115. Global Alpha Synuclein Sales Share by Type (2015-2020)
Table 116. Global Alpha Synuclein Revenue by Type (2015-2020) (USD Million)
Table 117. Global Alpha Synuclein Revenue Share by Type (2015-2020)
Table 118. Global Alpha Synuclein Sales by Application (2015-2020) (K Pcs)
Table 119. Global Alpha Synuclein Sales Share by Application (2015-2020)
Table 120. Global Alpha Synuclein Sales Forecast by Regions (2021-2025) (K Pcs)
Table 121. Global Alpha Synuclein Market Share Forecast by Regions (2021-2025)
Table 122. Global Alpha Synuclein Sales Forecast by Type (2021-2025) (K Pcs)
Table 123. Global Alpha Synuclein Market Share Forecast by Type (2021-2025)
Table 124. Global Alpha Synuclein Sales Forecast by Application (2021-2025)
Table 125. Global Alpha Synuclein Market Share Forecast by Application (2021-2025)
Table 126. Direct Channel Pros & Cons
Table 127. Indirect Channel Pros & Cons
Table 128. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Alpha Synuclein Picture
Figure 2. Global Sales Market Share of Alpha Synuclein by Type in 2019
Figure 3. AV-1950R Picture
Figure 4. AV-1947D Picture
Figure 5. BAN-0805 Picture
Figure 6. BIIB-054 Picture
Figure 7. DPC-003 Picture
Figure 8. Others Picture
Figure 9. Alpha Synuclein Sales Market Share by Application in 2018
Figure 10. Multiple System Atrophy Picture
Figure 11. Neurodegenerateive Disease Picture
Figure 12. Lewy Body Dementia Picture
Figure 13. Others Picture
Figure 14. Global Alpha Synuclein Market Status and Outlook (2015-2025) (USD Million)
Figure 15. United States Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Canada Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Mexico Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Germany Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 19. France Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 20. UK Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Russia Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Italy Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 23. China Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Japan Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Korea Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 26. India Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Southeast Asia Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Australia Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 29. Brazil Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Egypt Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Saudi Arabia Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 32. South Africa Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Turkey Alpha Synuclein Revenue (Value) and Growth Rate (2015-2025)
Figure 34. Global Alpha Synuclein Sales Market Share by Manufacturer in 2019
Figure 35. Global Alpha Synuclein Revenue Market Share by Manufacturer in 2019
Figure 36. Top 3 Alpha Synuclein Manufacturer (Revenue) Market Share in 2019
Figure 37. Top 6 Alpha Synuclein Manufacturer (Revenue) Market Share in 2019
Figure 38. Key Manufacturer Market Share Trend
Figure 39. Global Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 40. Global Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 41. Global Alpha Synuclein Revenue Market Share by Regions (2015-2020)
Figure 42. Global Alpha Synuclein Revenue Market Share by Regions in 2018
Figure 43. North America Alpha Synuclein Sales and Growth Rate (2015-2020)
Figure 44. Europe Alpha Synuclein Sales and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Alpha Synuclein Sales and Growth Rate (2015-2020)
Figure 46. South America Alpha Synuclein Sales and Growth Rate (2015-2020)
Figure 47. Middle East & Africa Alpha Synuclein Sales and Growth Rate (2015-2020)
Figure 48. North America Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 49. North America Alpha Synuclein Sales Market Share by Countries (2015-2020)
Figure 50. North America Alpha Synuclein Sales Market Share by Countries in 2018
Figure 51. North America Alpha Synuclein Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 52. North America Alpha Synuclein Revenue Market Share by Countries in 2018
Figure 53. United States Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 54. Canada Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 55. Mexico Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. Europe Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 57. Europe Alpha Synuclein Revenue Market Share by Countries (2015-2020)
Figure 58. Europe Alpha Synuclein Revenue Market Share by Countries in 2019
Figure 59. Germany Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. UK Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 61. France Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 62. Russia Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 63. Italy Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Asia-Pacific Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 65. Asia-Pacific Alpha Synuclein Sales Market Share by Regions 2019
Figure 66. Asia-Pacific Alpha Synuclein Revenue Market Share by Regions 2019
Figure 67. China Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. Japan Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 69. Korea Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 70. India Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 71. Southeast Asia Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. South America Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. South America Alpha Synuclein Sales Market Share by Countries in 2019
Figure 74. South America Alpha Synuclein Revenue Market Share by Countries in 2019
Figure 75. Brazil Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 76. Argentina Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 77. Middle East and Africa Alpha Synuclein Revenue and Growth Rate (2015-2020) (USD Million)
Figure 78. Middle East and Africa Alpha Synuclein Sales Market Share by Countries in 2019
Figure 79. Middle East and Africa Alpha Synuclein Revenue Market Share by Countries (2015-2020)
Figure 80. Middle East and Africa Alpha Synuclein Revenue Market Share by Countries in 2019
Figure 81. Saudi Arabia Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 82. Egypt Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 83. Turkey Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 84. South Africa Alpha Synuclein Sales and Growth Rate (2015-2020) (K Pcs)
Figure 85. Global Alpha Synuclein Sales and Growth Rate (2021-2025) (K Pcs)
Figure 86. Global Alpha Synuclein Revenue and Growth Rate (2021-2025) (USD Million)
Figure 87. North America Sales Alpha Synuclein Market Forecast (2021-2025) (K Pcs)
Figure 88. Europe Sales Alpha Synuclein Market Forecast (2021-2025) (K Pcs)
Figure 89. Asia-Pacific Sales Alpha Synuclein Market Forecast (2021-2025) (K Pcs)
Figure 90. South America Sales Alpha Synuclein Market Forecast (2021-2025) (K Pcs)
Figure 91. Middle East & Africa Sales Alpha Synuclein Market Forecast (2021-2025) (K Pcs)
Figure 92. Sales Channel: Direct Channel vs Indirect Channel
複数システム萎縮治療の世界市場 2020年 Market Overview The global Multiple System Atrophy Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Multiple…- インターロイキン7受容体サブユニットアルファの世界市場 2020年 Market Overview The global Interleukin 7 Receptor Subunit Alpha market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Interleu…
- インターロイキン1アルファの世界市場 2020年 Market Overview The global Interleukin 1 Alpha market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Interleukin 1 Alpha marke…
- アルファ2Cアドレナリン受容体の世界市場 2020年 Market Overview The global Alpha 2C Adrenergic Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Alpha 2C Adrener…
- レチノイン酸受容体アルファの世界市場 2020年 Market Overview The global Retinoic Acid Receptor Alpha market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinoic Acid Re…